Johnson Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $758K | Sell |
3,985
-144
| -3% | -$24.8K | 0.01% | 512 |
|
|
2026
Q1 | $697K | Sell |
4,129
-45
| -1% | -$7.7K | 0.01% | 503 |
|
|
2025
Q4 | $704K | Hold |
4,174
| – | – | 0.01% | 473 |
|
|
2025
Q3 | $603K | Buy |
4,174
+250
| +6% | +$34.1K | 0.01% | 536 |
|
|
2025
Q2 | $496K | Buy |
3,924
+283
| +8% | +$34.7K | ﹤0.01% | 549 |
|
|
2025
Q1 | $466K | Sell |
3,641
-42
| -1% | -$5.7K | ﹤0.01% | 547 |
|
|
2024
Q4 | $487K | Sell |
3,683
-1,753
| -32% | -$246K | ﹤0.01% | 539 |
|
|
2024
Q3 | $791K | Buy |
5,436
+1,611
| +42% | +$233K | 0.01% | 430 |
|
|
2024
Q2 | $525K | Sell |
3,825
-1,158
| -23% | -$155K | 0.01% | 484 |
|
|
2024
Q1 | $684K | Sell |
4,983
-55
| -1% | -$7.51K | 0.01% | 436 |
|
|
2023
Q4 | $684K | Sell |
5,038
-295
| -6% | -$36K | 0.01% | 419 |
|
|
2023
Q3 | $652K | Sell |
5,333
-223
| -4% | -$28.4K | 0.01% | 414 |
|
|
2023
Q2 | $705K | Sell |
5,556
-502
| -8% | -$65.2K | 0.01% | 410 |
|
|
2023
Q1 | $782K | Sell |
6,058
-136
| -2% | -$17.8K | 0.01% | 387 |
|
|
2022
Q4 | $813K | Sell |
6,194
-5
| -0.1% | -$646 | 0.01% | 375 |
|
|
2022
Q3 | $725K | Sell |
6,199
-330
| -5% | -$41K | 0.01% | 377 |
|
|
2022
Q2 | $768K | Buy |
6,529
+120
| +2% | +$14.2K | 0.01% | 370 |
|
|
2022
Q1 | $835K | Hold |
6,409
| – | – | 0.01% | 384 |
|
|
2021
Q4 | $978K | Sell |
6,409
-378
| -6% | -$58.5K | 0.01% | 357 |
|
|
2021
Q3 | $1.1M | Hold |
6,787
| – | – | 0.01% | 332 |
|
|
2021
Q2 | $1.11M | Sell |
6,787
-467
| -6% | -$71.9K | 0.02% | 312 |
|
|
2021
Q1 | $1.09M | Sell |
7,254
-705
| -9% | -$112K | 0.02% | 301 |
|
|
2020
Q4 | $1.21M | Sell |
7,959
-561
| -7% | -$80.2K | 0.02% | 272 |
|
|
2020
Q3 | $1.15M | Sell |
8,520
-352
| -4% | -$47.8K | 0.02% | 260 |
|
|
2020
Q2 | $1.21M | Sell |
8,872
-52
| -0.6% | -$6.63K | 0.02% | 240 |
|
|
2020
Q1 | $961K | Buy |
8,924
+358
| +4% | +$41.2K | 0.02% | 259 |
|
|
2019
Q4 | $1.03M | Buy |
8,566
+508
| +6% | +$56.7K | 0.02% | 315 |
|
|
2019
Q3 | $802K | Buy |
+8,058
| New | +$843K | 0.02% | 344 |
|
|
2018
Q2 | – | Sell |
-2,250
| Closed | -$240K | – | 640 |
|
|
2018
Q1 | $240K | Buy |
2,250
+239
| +12% | +$26.5K | 0.01% | 554 |
|
|
2017
Q4 | $214K | Buy |
2,011
+1
| +0% | +$107 | 0.01% | 577 |
|
|
2017
Q3 | $223K | Sell |
2,010
-480
| -19% | -$51.3K | 0.01% | 571 |
|
|
2017
Q2 | $257K | Buy |
2,490
+165
| +7% | +$16.3K | 0.01% | 537 |
|
|
2017
Q1 | $227K | Sell |
2,325
-3,930
| -63% | -$376K | 0.01% | 555 |
|
|
2016
Q4 | $553K | Sell |
6,255
-5,940
| -49% | -$541K | 0.02% | 346 |
|
|
2016
Q3 | $1.18M | Sell |
12,195
-735
| -6% | -$69.9K | 0.04% | 202 |
|
|
2016
Q2 | $1.11M | Buy |
12,930
+465
| +4% | +$41.7K | 0.04% | 209 |
|
|
2016
Q1 | $1.08M | Buy |
12,465
+270
| +2% | +$24.1K | 0.04% | 203 |
|
|
2015
Q4 | $1.38M | Buy |
12,195
+9,405
| +337% | +$1.02M | 0.05% | 186 |
|
|
2015
Q3 | $282K | Sell |
2,790
-135
| -5% | -$16.2K | 0.01% | 448 |
|
|
2015
Q2 | $359K | Sell |
2,925
-129
| -4% | -$15.4K | 0.01% | 407 |
|
|
2015
Q1 | $349K | Buy |
3,054
+129
| +4% | +$14.2K | 0.01% | 407 |
|
|
2014
Q4 | $295K | Hold |
2,925
| – | – | 0.01% | 460 |
|
|
2014
Q3 | $266K | Hold |
2,925
| – | – | 0.01% | 471 |
|
|
2014
Q2 | $250K | Hold |
2,925
| – | – | 0.01% | 452 |
|
|
2014
Q1 | $230K | Buy |
+2,925
| New | +$244K | 0.01% | 469 |
|
Other funds holding IBB
CB
Johnson Investment Counsel's IBB Position: Q2 2026 in Review
Johnson Investment Counsel reduced its iShares Biotechnology ETF (IBB) stake by 3.5% in Q2 2026, selling an estimated $24.8K and leaving 3,985 shares worth $758K. The position accounts for 0.01% of the portfolio, ranked #512.
Johnson Investment Counsel first reported a position in IBB in Q1 2014 and has held it in 45 quarters since. The position peaked at $1.38M in Q4 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Johnson Investment Counsel held 3,985 shares of iShares Biotechnology ETF worth $758K as of Q2 2026.
- Johnson Investment Counsel sold 144 iShares Biotechnology ETF shares in Q2 2026, an estimated $24.8K.
- iShares Biotechnology ETF made up 0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #512 holding.
- Johnson Investment Counsel first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 45 quarters since.
- Johnson Investment Counsel's iShares Biotechnology ETF position peaked at $1.38M in Q4 2015.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.